Launch Performance Monitoring and Control

To ensure that a newly launched drug yields the best return on investment, it’s essential to track its marketplace performance – and measure its success against established benchmarks and forecasts.  If expectations aren’t being met, corrective action needs to be taken.

At IMS, we help customers track key post-launch performance metrics, answering questions such as:

• Was the pricing strategy on target?
• Did the clinical trials provide important data?
• Is the new drug performing the way we anticipated?
• Is it gaining the forecasted market share?

We can detect early warning signs and their causes – and work with clients to advise on needed course corrections.

	To learn more about how IMS can help your company, contact us. For regional contact information, click here.

email this page     print this page